baber/WOPTO huggingface dataset:
Patent AU-2010321722-A1 (AU)
Title: Methods and compositions for producing squalene using yeast
Inventor: WALKER KEITH A
IPC: C12N1/00
Filed: 2010-11-22
Abstract: Provided herein compositions and methods for producing isoprenoids, including squalene. In certain aspects and embodiments provided are genetically converted yeast and uses therefore. In some aspects and embodiments, the genetically converted yeast produce isoprenoids, preferably squalene. Also are provided methods of producing squalene using a genetically converted yeast or a non-genetically converted yeast. The invention also provides squalene produced by genetically converted yeast or non-genetically converted yeast.
Patent AU-2010330077-A1 (AU)
Title: Pesticidal mixtures
Inventor: GEWEHR MARKUS
IPC: A01N39/04
Filed: 2010-12-03
Abstract: The present invention relates to an agrochemical mixture for increasing the health of a plant, comprising as active ingredients 1) a herbicidal compound (I) selected from the group consisting of: (i) Benzoic acids, selected from chloramben, dicamba and 2,3,6-TBA; (ii) Pyridine carboxylic acids, selected from clopyralid, fluroxypyr, picloram and triclopyr; (iii) Quinoline carboxylic acids, selected from quinclorac and quinmerac; (iv) benazolin-ethyl; and 2) a fungicidal compound (II) selected from the group consisting of N-(3',4',5'-trifluorobiphenyl-2-yl)- 3-difluoromethyl-1 -methyl-1H-pyrazole-4-carboxamide (common name: fluxapyroxad), N-[2-(4'-trifluoromethylthio)-biphenyl]-3-difluoromethyl-1 -methyl-1 H-pyrazole-4-carboxamide, N-(3',4'-dichloro-5-fluorobiphenyl-2-yl)-3-difluoromethyl-1-methylpyrazole-4-carboxamide (common name: bixafen), N-[2-(1,3-dimethylbutyl)-phenyl]-1,3-dimethyl-5-fluoro-1 H-pyrazole-4-carboxamide (common name: penflufen), N-(2-bicyclopropyl-2-yl-phenyl)-3- difluoromethyl-1 -methyl-1 H-pyrazole-4-carboxamide (common name: sedaxane), N- [1,2,3,4-tetrahydro-9-(1 -methylethyl)-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)- 1 -methyl-1 H-pyrazole-4-carboxamide (common name: isopyrazam), N-[2-(1,3-dimethylbutyl)-3-thienyl]-1 -methyl-3-(trifluoromethyl)-1 H-pyrazole-4-carboxamide (common name: penthiopyrad), boscalid, fluopyram, flutolanil, furametpyr, mepronil and thifluzamide in synergistically effective amounts. The present invention further relates to a method for improving the health of a plant, wherein the plant, the locus where the plant is growing or is expected to grow or plant propagation material from which the plant grows is treated with an effective amount of a mixture as defined above. In addition, the invention relates to the use of a mixture as defined above for synergistically increasing the health of a plant.
Patent AU-2011200683-A1 (AU)
Title: Stent-Valves for Valve Replacement and Associated Methods and Systems for Surgery
Inventor: DELALOYE STEPHANE
IPC: A61F2/24
Filed: 2011-02-17
Abstract: The present invention is directed to a stent-valve for cardiac valve replacement. The stent-valve comprises a valve component and a stent component housing the valve component. The stent component and the valve component are capable of a collapsed configuration for delivery to an implantation site by a catheter and an expanded configuration after implantation. The stent-valve comprises loop material on an exterior surface of the stent component.
Patent AU-2011201449-A1 (AU)
Title: Lawnmower
Inventor: KAZUKI SHIMOZONO
IPC: A01D43/073
Filed: 2011-03-30
Abstract: Abstract A rotary lawnmower (10) includes a shutter (40) for switching a location to 5 which grass cut by the blade (14) is to be discharged, and a shutter operating mechanism (50) for operating the shutter. The shutter operating mechanism (50) has a first shaft (51), a second shaft (52), a first link arm (53), and a second link arm (54), a third link arm (55), and an operating lever (61). The first shaft (51) is positioned on the housing (11). The first link arm (53) is capable of swinging about the first shaft (51) and has the operating io lever (61). The second shaft (52) is positioned adjacent to and parallel to the first shaft (51), is rotatably attached to the housing (11), and is linked to the shutter (40) via the third link arm (55). The second link arm (54) is attached to the second shaft (52) so that relative rotation is restricted, whereby the second link arm can swing about the second shaft (52), and is swing-driven by the first link arm (53). 51--
Patent AU-2011201920-A1 (AU)
Title: Self-inflating tyre assembly
Inventor: ALLEN LOSEY ROBERT
IPC: B60C23/00
Filed: 2011-04-28
Abstract: SELF-INFLATING TYRE ASSEMBLY 5 A self-inflating tyre assembly (10) includes a tyre (12) having a tyre cavity (40) between first and second sidewalls (30, 32) that extend respectively from first and second tyre core beads (34, 36) to a tyre tread region (38). At least one of the sidewalls is provided with an air tube peristaltic pump assembly (14). An air tube (42) has an internal tube air passageway and is positioned within a sidewall groove (126) in contacting io engagement with opposite groove surfaces surrounding the air tube. The sidewall groove operatively bends within a rolling tyre footprint to compress the air tube from an expanded diameter to a flat diameter adjacent the rolling tyre footprint. A core bead passageway extends (62) within a core bead adjacent the one tyre sidewall for operatively storing air evacuated from the air tube passageway. Conduits are provided to route air is from the air tube to the core bead passageway and valve mechanisms are positioned within the core bead passageway to control the flow of air from the core bead passageway into the tyre cavity. Preg --- 46 A.-Toutlet 14 S '------ ---- Tinlet FIG- 1
Patent AU-2011203285-A1 (AU)
Title: Enzymatic Oil-Degumming Method
Inventor: BORCH SOE JORN
IPC: C11C3/00
Filed: 2011-07-05
Abstract: Abstract A process of enzymatic degumming edible oils, comprising treating the edible oil with a lipid acyltransferase so as to transfer an acyl group from a major part of the phospholipid to one or more acyl acceptors, wherein the acyl acceptor may be 5 any compound comprising a hydroxy group. In one embodiment preferably the acyl acceptor is water and in another embodiment preferably the acyl acceptor is one or more stenols and/or stanols. When the acyl acceptor is a stanol and/or stenol, one or more sterol esters and/or stanol esters are produced. The lipid acyltransferase for use in the process of the present invention may comprises one 10 or more of the following amino acid sequences: SEQ ID No. 1, SEQ ID No. 3, SEQ ID No. 4, SEQ ID No. 5, SEQ ID No. 6, SEQ ID No. 7, SEQ ID No. 8, SEQ ID No. 9, SEQ ID No. 10, SEQ ID No. 11, SEQ ID No. 12, SEQ ID No. 13, SEQ ID No. 14 or SEQ ID No. 15, SEQ ID No. 16, SEQ ID No. 17, SEQ ID No. 18, SEQ ID No. 36, SEQ ID No. 38, SEQ ID No. 40, SEQ ID No. 41, SEQ ID No. 45, SEQ 15 ID No. 47, SEQ ID No. 50 or an amino acid sequence which has 75% or more identity thereto. A novel lipid acyltransferase comprising the amino acid sequence shown as SEQ ID No. 16 is also taught.
Patent AU-2011209476-A1 (AU)
Title: Ship drive system having a plurality of electric drive shafts
Inventor: HARTIG RAINER
IPC: B60L50/13
Filed: 2011-01-31
Abstract: A ship drive system (10) according to the invention comprises at least one first and one second drive shaft (11, 12) for driving a respective propulsion unit (2), in particular of a water jet, wherein each of the electric drive shafts (11, 12) comprises at least one speed-variable generator (4) driven by an internal combustion engine (3, 6) for generating a motor voltage having a variable amplitude and variable frequency, and at least one speed-variable drive motor (5) that is supplied with said voltage and coupled to the propulsion unit (2). The first and second drive shafts (11, 12) can be switched from a first operating state, in which they are electrically disconnected from each other, to a second operating state, in which they are electrically coupled to each other such energy can be transmitted from the at least one generator (4) of the one drive shaft (11, 12) to the at least one drive motor (5) of the other drive shaft (11, 12). To this end, the at least one generator (4) preferably comprises a superconductor winding. A preferred use of the ship drive system (1) is found in trimarans.
Patent AU-2011221418-A1 (AU)
Title: A method and system for wavelength specific thermal irradiation and treatment
Inventor: COCHRAN DON W
IPC: B29C49/64
Filed: 2011-09-09
Abstract: A METHOD AND SYSTEM FOR WAVELENGTH SPECIFIC THERMAL IRRADIATION AND TREATMENT Abstract 5 There is disclosed herein a system for non-contact thermal treatment of plastic target components prior to molding or processing operations comprising: a means operative to locate plastic target components in a manner facilitating the application of radiant heating; and a thermal monitoring and control section into which the plastic components are located for exposure, the thermal monitoring and control section 10 comprising one or more solid state RED-based radiant heating elements operative to emit radiant energy in a narrow wavelength band matching a desired absorptive characteristic of the plastic target components via a direct electrical current-to-photon conversion process.
Patent AU-2011226933-A1 (AU)
Title: Specimen retrieval apparatus
Inventor: GROVER SIMON RODERICK
IPC: A61B17/29
Filed: 2011-09-28
Abstract: SPECIMEN RETRIEVAL APPARATUS Abstract A specimen retrieval apparatus (10) includes a housing (110) having an elongated tubular member (300) extending distally therefrom. The elongated tubular member (300) defines a longitudinal axis (X). An end effector assembly (400) is coupled to a distal end of the elongated tubular member (300). The end effector assembly (400) is configured to retain a specimen retrieval bag (500, 600, 600') thereon. An articulation mechanism (170) is operatively coupled to the elongated tubular member (300) and the end effector assembly (400). The articulation mechanism (170) is configured for selectively articulating the end effector assembly (400) with respect to the longitudinal axis (X) of the elongated tubular member (300). C~C) CV)% 1cm
Patent AU-2011227424-A1 (AU)
Title: Universal framing square
Inventor: CHAPPELL STEVE K
IPC: B43L7/027
Filed: 2011-03-15
Abstract: The Chappell Universal Square ™ solves the problems associated with standard framing squares and provides a dynamic framing square bearing novel indicia and a novel arrangement of same for direct application to framing members during construction of complicated framing systems of equal and/or unequal pitched members. Typically, squares are limited to use with a single base unit of measurement, e.g. inches or millimeters, and provide limited tabulated information for use in calculating lengths, distances, and angles at which to cut framing members. The present invention is a tool that provides universal applicability for use in building both simple and complex structures according to metric and standard/imperial measurement systems. The present invention provides tabulated calculations aligned with indicia that enable construction of equal and complex unequal pitch framing members without necessitating the execution of complex trigonometric calculations.
Patent AU-2011236792-A1 (AU)
Title: Liquid-crystal display device and three-dimensional display system
Inventor: KITAYAMA MASAE
IPC: H04N13/04
Filed: 2011-04-07
Abstract: Disclosed is a liquid-crystal display device (100) that performs display in a three-dimensional display mode. The liquid-crystal display device (100) includes a plurality of pixels, and left-eye image data and right-eye image data are alternately written to each of the pixels for each two consecutive vertical scanning periods. Each of the pixels shows the same polarity over the two vertical scanning periods during which the left-eye image data is written, and shows the same polarity over the two vertical scanning periods during which the right-eye image data is written. With this, the liquid-crystal display device (100) can perform three-dimensional display during which unevenness in display is suppressed.
Patent AU-2011254022-A1 (AU)
Title: Membrane-free filter and/or integral framing for filter
Inventor: CRABTREE LAMONTE A
IPC: B01D39/02
Filed: 2011-12-14
Abstract: A filter for an electronics cooling unit of a telecommunications base station the electronics cooling unit adapted to receive fresh air into a housing of the cooling unit through an opening communicating with the external environment. The filter includes a structural support configured to be mounted to said housing, a gasket sealingly engaging the structural support and adapted to engage the housing; and a filter media supported by the structural support, the filter media being free of a membrane type layer and including a fiber entanglement selected to prevent ingress of water sufficient to pass a salt fog test consistent with GR-487-CORE and in accordance with ASTM B 117. I T, Cll
Patent AU-2011258027-A1 (AU)
Title: Method and apparatus to control fluid flow subsea wells
Inventor: SMITH DAVID RANDOLPH
IPC: E21B7/12
Filed: 2011-05-27
Abstract: The present invention is directed to methods and apparatus to construct subsea wells with redundant parallel fluid flow control systems to allow new methods to stop subsea blow outs. More specifically, this invention provides methods and apparatus to construct subsea wells with a plurality of redundant parallel paths allowing for the first time drill pipe and other intervention conduits, wire line, and fluids to be deployed below a damaged drilling riser and or a damaged blow out preventer through a separate blow out preventer and riser system presented in this invention.
Patent AU-2011264613-A1 (AU)
Title: Microcapsule suspensions including high levels of agriculturally active ingredients
Inventor: XU WEN
IPC: A01N25/28
Filed: 2011-04-11
Abstract: Materials and methods for the formation of microcapsules that include a high concentration of agriculturally active ingredients (AIs) and a lipophilic polymer encapsulated within a polymeric shell formed via an interfacial polycondensation reaction. Under some conditions, these microcapsules may be formed using less lipophilic solvent than is required using convention microencapsulation techniques. These inventive methods include forming an oil-in-water emulsion in some cases using a first polymer as a lipophilic solvent for the AI and forming a microcapsule that includes the AI and polymer. Other methods include forming a microcapsule that includes a lipophilic monomer, agriculturally active ingredient and initiator having a polymeric shell then elevating the temperature to initiate polymerization of the monomer with the microcapsule.
Patent AU-2011265327-A1 (AU)
Title: Active casing hanger hook mechanism
Inventor: GETTE NCHOLAS PETER
IPC: E21B33/035
Filed: 2011-12-19
Abstract: A subsea wellhead assembly includes a housing with a bore. A hanger is lowered into the housing, the hanger having at least one centralizing finger with a hook for engaging a corresponding hook an activation ring carried by the hanger via a shear pin. A load ring is carried on the hanger and supported initially within a recess formed on the exterior of the hanger. At the correct depth within the housing, coinciding with a shoulder on the inner diameter of the housing, the pin is sheared under the weight of the casing string and the hooks disengage to allow the load ring on the hanger to slide outward and create a path for the casing load to be transferred from the hanger to the hanger load ring, to a housing load ring, and ultimately the housing. 106 38 -34 20 -32 , 18 3 6 2 -1 19 -26281 58 54 56-, 78 -60 80 70 -72 74-- 76 Ax Fig. 1
Patent AU-2011274619-A1 (AU)
Title: miRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway
Inventor: BEREZIKOV EUGENE
IPC: A61P35/00
Filed: 2011-07-01
Abstract: The invention relates to the diagnostic and therapeutic uses of a miRNA molecule, an equivalent or a source thereof in a disease and condition associated with melanoma or a disease or a condition associated with activated BRAF pathway.
Patent AU-2011281697-A1 (AU)
Title: Method for clarifying a wine sediment
Inventor: SCHAUZ FRANK
IPC: C12G1/00
Filed: 2011-07-18
Abstract: The invention relates to a method for clarifying a sediment (101, 21), in particular a wine sediment, in a system comprising at least one solid bowl worm centrifuge (8, 18) for the centrifugal clarification (105, 205) of the sediment (101, 201) forming a solid phase (106, 206) and a liquid phase (107, 207), wherein before and/or during the centrifugal clarification (105, 205) a fining (103, 203) of the sediment (101, 201) is carried out by adding at least one fining agent (104, 204).
Patent AU-2011290751-A1 (AU)
Title: Binding proteins for Hepcidin
Inventor: TRENTMANN STEFAN
IPC: C07K14/435
Filed: 2011-08-16
Abstract: The present invention relates to novel, specific-binding therapeutic and/or diagnostic proteins directed against Hepcidin, which proteins preferably are muteins of a lipocalin protein. The invention also relates to nucleic acid molecules encoding such proteins and to methods for generation and use of such proteins and nucleic acid molecules. Accordingly, the invention also is directed to pharmaceutical and/or diagnostic compositions comprising such a lipocalin proteins, including uses of these proteins.
Patent AU-2011293387-A1 (AU)
Title: Biomaterials with enhanced properties and devices made therefrom
Inventor: CUNANAN CRYSTAL M
IPC: A61L27/36
Filed: 2011-08-24
Abstract: Biomaterials with enhanced properties such as improved strength, flexibility, durability and reduced thickness are useful in the fabrication of biomedical devices, particularly those subjected to continuous or non-continuous loads where repeated flexibility and long-term durability are required. These enhanced properties can be attributed to elevated levels of elastin, altered collagen types, and other biochemical changes which contribute to these enhanced properties. Examples of devices which would be improved by use of such tissue include heart valves, including percutaneous heart valves, and vascular grafts, patches and the like. Such enhanced materials can be sourced from specific populations of animals, such as neonatal calves, or in range-fed adult cattle, or can be fabricated or created from cell populations exhibiting such properties. In one embodiment, glutaraldehyde-fixed neonatal pericardial tissue is used to create leaflets in a percutaneous heart valve, and may be used without chemical fixation, with or without processes to remove residual cellular membranes, and utilized as a scaffold material for tissue engineering
Patent AU-2011298235-A1 (AU)
Title: Anticaries compositions and probiotics/prebiotics
Inventor: MIRA OBRADOR ALEJANDRO
IPC: A61K38/16
Filed: 2011-08-31
Abstract: The present invention relates to various specific bacterial strains isolated from individuals without caries, and characterized in that the strains have an inhibitory activity against cariogenic organisms. The invention also relates to a method for isolating said strains, as well as bioactive peptides, i.e. antimicrobial peptides of human and bacterial origin which also exhibit anticaries activity. The invention additionally relates to pharmaceutical compositions and/or probiotics/prebiotics, functional foods, mouthwashes, toothpaste, chewing gum, etc. that include at least one of the strains and/or at least one of the bioactive peptides of the invention or a combination thereof, and which are useful in the treatment and/or prevention of infectious diseases of the oral cavity, preferably caries.
Patent AU-2011305161-A1 (AU)
Title: Controlled release formulations of opioids
Inventor: RUDNIC EDWARD M
IPC: A61P25/04
Filed: 2011-09-23
Abstract: Pharmaceutical formulations containing opioid components that each has a release profile. The components may provide immediate or controlled release of the opioid. The invention is also directed to methods of controlling release of one or more opioid compounds and methods of treating pain.
Patent AU-2011312518-A1 (AU)
Title: Combination treatment for rosacea
Inventor: GRAEBER MICHAEL
IPC: A61K31/4168
Filed: 2011-09-27
Abstract: The invention relates to a method of treating erythema and/or telangiectasia associated with rosacea in a patient in need thereof by topically administering an effective amount of a combination of brimonidine or a pharmaceutically acceptable salt thereof and oxymetazoline or a pharmaceutically acceptable salt thereof to the site of erythema and/or telangiectasia on the skin of the patient. The invention further relates to topical compositions including the combination of compounds and a pharmaceutically acceptable carrier.
Patent AU-2011313993-A1 (AU)
Title: External controller for an implantable medical device with dual microcontrollers for improved graphics rendering
Inventor: AGHASSIAN DANIEL
IPC: G06F19/00
Filed: 2011-10-05
Abstract: An improved external controller with dual microcontrollers useable with an implantable medical device is disclosed. The external controller comprises a low speed (low frequency) microcontroller and a high speed (high frequency) microcontroller. The low speed microcontroller receives telemetry data from the medical device, converts data into graphical commands, and transmits commands to the high speed microcontroller. The high speed microcontroller interprets the graphical commands, retrieves images indicative of the commands from a storage device, and renders the images onto a display screen. The high speed microcontroller may also process more complicated data sent from the low speed microcontroller, and return the results to the low speed microcontroller to allow it to form the graphics command for the high speed microcontroller to execute.
Patent AU-2011325934-A1 (AU)
Title: Metabolized conditioned growth medium and methods of use
Inventor: GRUBER JAMES VINCENT
IPC: A61K35/33
Filed: 2011-11-11
Abstract: Compositions comprising metabolized conditioned growth medium and/or metabolized cell extract and methods of use are described. The metabolized conditioned growth medium and metabolized cell extract compositions may be formulated with an acceptable carrier into injectable or topical formulations, for example, as a cream, lotion or gel, and may be used in cosmeceutical or pharmaceutical applications. The metabolized conditioned growth medium and metabolized cell extract may also be further processed to concentrate or reduce one or more factors or components contained within the metabolized conditioned growth medium or metabolized cell extract. The growth medium may be conditioned by any eukaryotic cell. The metabolized conditioned growth medium and metabolized cell extract may be used to prevent or treat a condition, for example, a skin condition.
Patent AU-2011331908-A1 (AU)
Title: Drought tolerant plants
Inventor: BORRELL ANDREW KENNNETH
IPC: A01H5/10
Filed: 2011-11-15
Abstract: The present specification teaches the generation of drought tolerant plants. The present disclosure enables manipulation of a phenotypic characteristic referred to herein as "stay-green" to generate drought tolerant plants by recombinant, mutagenic and/or breeding and selection methods. Plant management practice systems to increase crop yield and harvest efficiency in water-limited environments are also taught herein.